Drug details

Invokamet XR (canagliflozin and metformin hydrochloride)

type of

Invokamet XR (canagliflozin and metformin hydrochloride extended-release) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both canagliflozin and metformin is appropriate.

This drug may have the following side effects:

• nausea,
• headache,
• vomiting,
• indigestion,
• diarrhea,
• weakness,
• gas,
• increased urination, 
• urinary tract infection,
• genital yeast infections,
• abdominal discomfort,
• thirst, and
• vaginal itching.

The following drugs are related to Invokamet XR, either as a replacement or used together:

• Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride)
• Zegalogue (dasiglucagon injection)
• Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets)
• Semglee (insulin glargine injection)
• Lyumjev (insulin lispro-aabc injection)